Evolutionary Genomics Inc Common Stock (CE) (FNAM)
USOTC
Year End December 30 2022 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -28.968 | -27.401 | -24.629 | -48.494 | -88.924 | -85.071 |
Return on Equity (%) | -111.396 | -148.341 | -3037.143 | 184.907 | 98.908 | 44.996 |
Return on Invested Capital (%) | 13.432 | -21.2 | -23.166 | -68.343 | -54.208 | -39.583 |
Operating Margin (%) | -3242.424 | -955.652 | -618.699 | -20761.538 | N/A | N/A |
Net Profit Margin (%) | -2369.697 | -1166.087 | -864.228 | -15361.538 | N/A | N/A |
Book Value Per Share | 0.067 | -0.103 | -0.298 | -0.537 | -0.681 | -0.615 |
Earnings Per Share | -0.133 | -0.228 | -0.181 | -0.34 | -0.418 | -0.273 |
Cash Per Share | 0.15 | 0.022 | 0.008 | 0.037 | 0.029 | 0.07 |
Working Capital Per Share | 0.201 | 0.038 | 0.017 | 0.047 | 0.032 | 0.063 |
Operating Profit Per Share | 0.006 | 0.02 | 0.021 | 0.002 | N/A | 0.124 |
EBIT Per Share | -0.182 | -0.187 | -0.129 | -0.459 | -0.38 | -0.235 |
EBITDA Per Share | -0.182 | -0.187 | -0.129 | -0.459 | -0.38 | -0.235 |
Free Cash Flow Per Share | -0.14 | -0.235 | -0.188 | -0.409 | -0.559 | -0.398 |
Year End December 30 2022 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.88M | 5.88M | 5.88M | 5.88M | 5.88M | 6.66M |
Market Cap | 5.32k |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 6.66M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -99.82% |
52 Week High | 0.45 |
52 Week Low | 0.0008 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.